Replay available

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call

BIO-key International, Inc. (NASDAQ: BKYI) Q2 2026 earnings conference call, held 2026-08-14. Replay captured from the company's public earnings webcast.

Fri, August 14, 2026 at 10:00 AMendedReplay
BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Bill Jones

Investor Relations

Mike DePasquale

Chairman & CEO

C.C. Welch

CFO

Jack Vanderaardy

Analyst, Maxim Group

Dan Kamhis

Private Investor

Replay transcript excerpt

Good morning, everyone. Thank you for standing by and welcome to Bio-key International's second quarter 2026 conference call. During management's prepared remarks, all participants will be in listen-only mode. Afterwards, listeners will be invited to participate in a question and answer session. As a reminder, this conference is being recorded today, Friday, August 14, 2026. I will now turn the call over to Bill Jones of Investor Relations. Please go ahead. Thank you, Chloe. Hosting today are BioKeys Chairman and CEO Mike DePasquale and its CFO, C.C. Welch. As a reminder, today's call and webcast, as well as answers to investor questions, include forward-looking statements. These are subject to risks and uncertainties that may cause actual results to differ materially from current expectations. Words such as anticipate, believe, expect, plan, or project, and similar words identify and express forward-looking statements. These statements are made based on beliefs, assumptions, and information currently available to management pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act For a more complete description of these risks and uncertainties that affect future performance, please see risk factors in the company's annual report on Form 10-K and the current Form 10-Q filed with the SEC. Listeners are cautioned not to place undue reliance on forward-looking statements made as of today, and the company makes no obligation to revise or disclose revisions to forward-looking statements to reflect circumstances or events occurring after this call. Now, I'll turn the call over to Mike to begin. Mike? Thanks, Bill, and thank you all for joining us this morning. After my remarks, CeCe will review the financials, and then we will take investor qu...

More from Bio-key International, Inc.